Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT2 | P23786 | 1/20 | 0.32 |
| ▸ | ACLY | P53396 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3647978 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28778140 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28954899 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL3955192 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL247923 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28954895 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28307091 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| Water SCHEMBL28670203 | 0.97 | CPT2 (0.31) | CPT2ACLY | |
| SCHEMBL27553304 | 0.89 | — | — | |
| SCHEMBL290602 | 0.89 | SMN1; SMN2 (0.41) | CPT2ACLYSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4030921-B1 | WHEY-BASED NUTRITIONAL COMPOSITIONS FORTIFIED WITH CALCIUM | NESTLE SA (CH) | 2024-02-21 | — | — | EP | claimed |
| US-11534458-B2 | Phosphorus-sparing nutritional composition | ALBION LABORATORIES, INC. (US) | 2022-12-27 | — | — | US | claimed |
| US-20210137975-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2021-05-13 | — | — | US | claimed |
| EP-1755578-B2 | CHEWABLE, SUCKABLE AND SWALLOWABLE TABLET CONTAINING A CALCIUM-CONTAINING COMPOUND AS AN ACTIVE SUBSTANCE | TAKEDA AS (NO) | 2018-11-28 | — | — | EP | claimed |
| CN-108634242-A | Green pepper fiber crops jujube pantry pickles and production method | 中玺（天津）枣业技术工程中心 | 2018-10-12 | — | — | CN | claimed |
| CN-108618033-A | Spicy jujube is gone with rice or bread pickles and production method | 中玺（天津）枣业技术工程中心 | 2018-10-09 | — | — | CN | claimed |
| CN-108606285-A | Compound fruity jujube pickles and production method | 中玺（天津）枣业技术工程中心 | 2018-10-02 | — | — | CN | claimed |
| CN-108495621-A | Stablize agreeable to the taste vitamin C and zinc contains tablet composition | 诺维克斯科技私人有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-107811269-A | A kind of health-care extract fried bean sauce | 柳城奇货居企业管理服务有限公司 | 2018-03-20 | — | — | CN | claimed |
| WO-2017123103-A1 | STABLE AND PALATABLE COMPOSITION OF VITAMIN C AND ZINC LOZENGE TABLETS | DEE, KENNIE U. (PH) | 2017-07-20 | — | — | WO | claimed |
| US-20050196469-A1 | Micronutrient supplement combination for acne treatment and prevention | THYS-JACOBS SUSAN (US) | 2005-09-08 | — | — | US | claimed |
| EP-1150580-A1 | CALCIUM SUPPLEMENTED FOOD PRODUCTS AND NOVEL CALCIUM-CONTAINING INGREDIENT | Nutrahealth Ltd. (UK) (GB) | 2001-11-07 | — | — | EP | claimed |
| EP-0697877-B1 | PSYLLIUM DRINK MIX COMPOSITIONS | PROCTER & GAMBLE (US) | 2001-09-19 | — | — | EP | claimed |
| EP-1104998-A1 | COMPOSITION | Advanced Nutricional Foods Pty. Limited (AU) | 2001-06-13 | — | — | EP | claimed |
| WO-2000045650-A1 | CALCIUM SUPPLEMENTED FOOD PRODUCTS AND NOVEL CALCIUM-CONTAINING INGREDIENT | NUTRAHEALTH LTD. (UK) (GB) | 2000-08-10 | — | — | WO | claimed |
| WO-2000010402-A1 | COMPOSITION | ADVANCED NUTRITIONAL FOODS PTY. LIMITED (AU) | 2000-03-02 | — | — | WO | claimed |
| EP-0697821-B1 | CHOLESTEROL LOWERING DRINK MIX COMPOSITIONS | PROCTER & GAMBLE (US) | 1998-11-18 | — | — | EP | claimed |
| EP-0542912-A1 | CALCIUM AND TRACE MINERAL SUPPLEMENTS. | PROCTER & GAMBLE (US) | 1993-05-26 | — | — | EP | claimed |
| US-5151274-A | Calcium citrate malate for bone disorders | THE PROCTER & GAMBLE COMPANY (US) | 1992-09-29 | — | — | US | claimed |
| WO-1992002235-A1 | CALCIUM AND TRACE MINERAL SUPPLEMENTS | THE PROCTER & GAMBLE COMPANY (US) | 1992-02-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11534458-B2 | Phosphorus-sparing nutritional composition | PHPT1, PPA1, PTH1R | CPT2 813/4885ACLY 758/4885SMN1; SMN2 1232/4885 |
| US-20210137975-A1 | PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION | PHPT1, PPA1, PTH1R | CPT2 813/4885ACLY 758/4885SMN1; SMN2 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.